XKRX:950200 (USA)
Â
Korean Depository Receipts
â‚©
3,155
-75 (-2.32%)
Sep 10
Business Description
Psomagen Inc
NAICS : 621512
SIC : 2835
ISIN : KR8840150005
Share Class Description:
XKRX:950200: Korean Depository ReceiptsTotal Employee Number:
88Compare
Compare
Traded in other countries / regions
950200.Korea Index Membership
KOSDAQ Composite Index IPO Date
2020-07-13Description
Psomagen Inc provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.67 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | 4.48 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 3.89 | |||||
Beneish M-Score | -2.64 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.9 | |||||
3-Year EBITDA Growth Rate | -11 | |||||
3-Year EPS without NRI Growth Rate | -22.8 | |||||
3-Year FCF Growth Rate | 73.8 | |||||
3-Year Book Growth Rate | -8.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 23.78 | |||||
9-Day RSI | 39.61 | |||||
14-Day RSI | 46.15 | |||||
3-1 Month Momentum % | 8.42 | |||||
6-1 Month Momentum % | -12.04 | |||||
12-1 Month Momentum % | -24.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.45 | |||||
Quick Ratio | 1.93 | |||||
Cash Ratio | 1.3 | |||||
Days Inventory | 54.72 | |||||
Days Sales Outstanding | 46.87 | |||||
Days Payable | 33.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -1.43 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 25.23 | |||||
Operating Margin % | -1.43 | |||||
Net Margin % | 3.66 | |||||
EBITDA Margin % | 3.84 | |||||
FCF Margin % | 6.21 | |||||
OCF Margin % | 7.63 | |||||
ROE % | 7.48 | |||||
ROA % | 4.04 | |||||
ROIC % | -2.24 | |||||
3-Year ROIIC % | -29.7 | |||||
ROC (Joel Greenblatt) % | -8.91 | |||||
ROCE % | -4.82 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 26.73 | |||||
Price-to-Owner-Earnings | 12.85 | |||||
PS Ratio | 1.09 | |||||
PB Ratio | 1.9 | |||||
Price-to-Tangible-Book | 2.28 | |||||
Price-to-Free-Cash-Flow | 16.39 | |||||
Price-to-Operating-Cash-Flow | 13.52 | |||||
EV-to-EBIT | -32.49 | |||||
EV-to-EBITDA | 25.28 | |||||
EV-to-Revenue | 0.98 | |||||
EV-to-FCF | 16.75 | |||||
Price-to-GF-Value | 0.6 | |||||
| Price-to-Net-Current-Asset-Value | 6.28 | |||||
Earnings Yield (Greenblatt) % | -3.08 | |||||
FCF Yield % | 5.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Psomagen Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 57,288.578 | ||
| EPS (TTM) (â‚©) | 118 | ||
| Beta | -0.009 | ||
| 3-Year Sharpe Ratio | -0.55 | ||
| 3-Year Sortino Ratio | -0.77 | ||
| Volatility % | 38.37 | ||
| 14-Day RSI | 46.15 | ||
| 14-Day ATR (â‚©) | 344.46132 | ||
| 20-Day SMA (â‚©) | 3403.75 | ||
| 12-1 Month Momentum % | -24.01 | ||
| 52-Week Range (â‚©) | 2380 - 4690 | ||
| Shares Outstanding (Mil) | 19.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Psomagen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Psomagen Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Psomagen Inc Frequently Asked Questions
What is Psomagen Inc(XKRX:950200)'s stock price today?
The current price of XKRX:950200 is â‚©3155.00. The 52 week high of XKRX:950200 is â‚©4690.00 and 52 week low is â‚©2380.00.
When is next earnings date of Psomagen Inc(XKRX:950200)?
The next earnings date of Psomagen Inc(XKRX:950200) is .
Does Psomagen Inc(XKRX:950200) pay dividends? If so, how much?
Psomagen Inc(XKRX:950200) does not pay dividend.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers